Records containing: NAFLD
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-12-03Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals - Reversibility and Mechanistic Studies.
-
CLINICAL_TRIALS study record update · 2024-11-27A Feasibility Trial of One-carbon Metabolism Cofactor Supplements for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)
-
CLINICAL_TRIALS study record update · 2024-11-25Effects of Phytosterol Supplementation on Serum Lipid Profile, Liver Enzymes, Insulin, Adiponectin, and Inflammatory Status in Patients with Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2024-11-25The Effect of Time-restricted Eating on Liver Metabolism
-
CLINICAL_TRIALS study record update · 2024-11-21Diet Intervention to Promote Liver and Brain Health in Adults With Non-alcoholic Fatty Liver Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-11-13Integrated Multi-omics and Machine Learning-driven Personalized Treatment of Obesity-associated Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2024-10-26Comparison Between 14/10 Intermittent Fasting and the Southern Italian Mediterranean Diet in the Variation of NAFLD Score, Inflammatory Indices and Intestinal Microbiota
-
CLINICAL_TRIALS study record update · 2024-10-24A Phase 2A, Single Center, Open-label, Single-arm, 24-week Study to Evaluate the Safety, Tolerability and Efficacy of Saroglitazar Magnesium 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (EVIDENCES VIII)
-
CLINICAL_TRIALS study record update · 2024-10-23Genetic-specific Effects of Fructose on Liver Lipogenesis
-
CLINICAL_TRIALS study record update · 2024-10-02Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet on Diagnostic and Prognostic Markers in Liver Disease
-
CLINICAL_TRIALS study record update · 2024-09-27Phase I Open Label, Drug-Drug Interaction, Study to Evaluate the Effect of Itraconazole and Phenytoin on the Pharmacokinetics of ASC41 in Healthy Volunteers and A Study to Evaluate the PK, Safety and Tolerability in Subjects With Non-alcoholic Fatty Liver Disease (NAFLD).
-
CLINICAL_TRIALS study record update · 2024-09-27A Randomized, Double-Blind, Placebo-Controlled Phase Ib Study to Evaluate Safety, Tolerability and Pharmacokinetics and Pharmacodynamics (Biomarkers) of ASC41 Tables in Overweight and Obese Subjects
-
CLINICAL_TRIALS study record update · 2024-09-27A Randomized, Single Center, Open-label, Phase I Study to Evaluate the Effect of Food and Fasting on the Pharmacokinetics of ASC41 Tablets in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2024-09-25Complex Lifestyle Modification in the Treatment of Non-alcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2024-09-19Polycystic Ovarian Syndrome Women with NAFLD and Obstructive Sleeping Apnea: Program of Lifestyle Changes
-
CLINICAL_TRIALS study record update · 2024-08-30Dietary Intervention for Low Free Sugars in Children With Non-alcoholic Fatty Liver Disease: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-08-16NAFLD Stigma vs MAFLD Stigma and Their Impact on Quality of Life in Egyptian Patients: A Survey Study
-
CLINICAL_TRIALS study record update · 2024-07-09Vigorous- Versus Moderate-intensity Exercise to Reduce Liver Fat in Adults With Obesity and Non-alcoholic Fatty Liver Disease (NAFLD): A Randomized Controlled Equivalence Trial
-
CLINICAL_TRIALS study record update · 2024-05-31Determination of Biological Activity of Enriched Serum Among Healthy Participants After Consumption of the Food Supplement TOTUM-448
-
CLINICAL_TRIALS study record update · 2024-05-24Effects of Almonds in Glucose-intolerant Adults - a Randomised Controlled Study on Muscle Mass and Obesity, Energy Metabolism and Lipidome, NON-alcoholic Fatty Liver and Inflammation (AGAMEMNON)
-
CLINICAL_TRIALS study record update · 2024-05-14Effectiveness of Bariatric Surgery for Nonalcoholic Fatty Liver Diseases/Nonalcoholic Steatohepatitis With Fibrosis : A Prospective, Multicentric Cohort Study
-
CLINICAL_TRIALS study record update · 2024-05-14Double-blind, Randomized, Placebo-controlled, Phase II Dose-finding Study Comparing Different Doses of ZED1227 Capsules With Placebo in the Treatment of Non-alcoholic Fatty Liver Disease (NAFLD) With Significant Fibrosis
-
CLINICAL_TRIALS study record update · 2024-05-10A Randomized, Double-Blind, Placebo-Controlled Study, to Assess the Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL)
-
CLINICAL_TRIALS study record update · 2024-05-07Effect of Consumption of Millets Based Diet on, Clinical Characteristics, Metabolic Profile, and Gut Microbiome in Patients With Non-alcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2024-05-03A Phase 2B, Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rencofilstat in Adult Subjects With Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis